Abstract
Nisoldipine is a second generation dihydropyridine calcium antagonist having characteristics of strong coronary artery dilating effect and less negative inotropic action. The purpose of this study was to evaluate the effect of nisoldipine on the cardiac function (systolic and diastolic) and the exercise tolerance in patients with hypertrophic cardiomyopathy (HCM).Subjects: Twenty-three patients with HCM were studied.Methods: We measured the following indices using M-mode and pulsed wave Doppler echocardiography before and after nisoldipine therapy; left ventricular fractional shortening (LVFS), isometric relaxation time (IRT), deceleration half-time (DHT) of early diastolic mitral (E) flow, late diastolic mitral (A) flow and A/E ratio. Symptomlimited treadmill exercise test was performed. Exercise tolerance (EX) time was measured. Nisoldipine of 10mg/day was orally administered. Same tests were repeated on day 14 and after 6 months.Results: 1) Short-term effects; LVFS did not change (55.9±5.9%→57.0±7.4%, NS) after 2 weeks. However, LV diastolic function significantly improved (IRT; 92.1±7.7 ms→85.2±11.6 ms, p<0.05, DHT; 70.7±16.2 ms→63.3±3.7 ms, p<0.05). EX time increased (8.9±2.6 min→ 10.0±3.3 min, p<0.05). 2) Long-term effects; LV diastolic function had a tendency toward improvement, but is statistically not significant (IRT; 91.1±7.6→83.8±11.6 ms, DHT; 73.1±23.4→61.0±11.4 ms, A/E; 1.26±0.29→1.11±0.36) after 6 months. EX time was significantly increased (9.4±1.7→ 10.1±1.7 min, p<0.05).Conclusions: Nisoldipine improved LV diastolic dysfunction and exercise tolerance in patients with HCM. These effects were similar to the first generation calcium antagonists. LV diastolic dysfunction may be improved due to the reduction of intracellular calcium concentration and the relief of myocardial ischemia by strong coronary artery dilating effect. However, nisoldipine did not affect the LV systolic function because of its less negative inotropic effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Michael VG (1985) Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 72:853–864
Bonow RO (1992) Determinants of Exercise Capacity in Hypertrophic Cardiomyopathy. J Am Coll Cardiol 19: 513–515
Cyran J, Knaup G (1990) Nisoldipine bei stabiler Angina pectoris. Eine vergleichende Untersuchung zweier Nisoldipine-Dosierungen gegen Diltiazem, Therapiewoche 40:456–461
Ellestad MH (1986) Stress Testing. Principles and Practice, 3rd ed. Philadelphia F. A. Davis
Hanrath P, Mathey DG, Siegert R, Bleifeld W (1980) Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophic study. Am J Cardiol 45:15–23
Kitabatake A, Mikami T, Mano T, Tanouchi J (1993) Echocardiographic findings in Cardiomyopathy (in Japanese). J Jpn Soc Int Med 82:209–214
Koide T, Kakihara M, Takabatake Y et al. (1981) Long-term clinical effects of calcium inhibitors in hypertrophic cardiomyopathy compared to the effect of beta-blocking agents. Jpn Heart J 22: 87–102
Kondo S, Nishioka T, Uehata A et al. (1986) Effect of left ventricular diastolic function by nisoldipine, a new long acting, calcium-channel blocker, analysis by pulsed Doppler method (Abstract, in Japanese). Jpn J Appl Physiol 16:134
Lewis BS, Shefer A, Merdler A, Flugelman MY, Hardoff R, Halon DA (1988) Effect of the second-generation calcium channel blocker nisoldipine on left ventricular contractility in cardiac failure. Am Heart J 115:1238–1244
Lorell BH, Paulus WJ, Grossman WW, Wynne J, Cohn PF (1982) Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 65:499–507
Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wideangle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 48:418–428
Nayler WG, Williams A (1978) Relaxation in heart muscle: Some morphologic and biochemical considerations. Eur J Cardiol 7 (Suppl): 35
Nihoyannopoulos P, Karatasakis G, Frenneaux M, Mckenna WJ, Oakley CM (1992) Diastolic function in Hypertrophic Cardiomyopathy: Relation to Exercise Capacity. J Am Coll Cardiol 19:536–540
Rosing DR, Idanpaan-Heikkila U, Maron BJ, Bonow RO, Esptein SE (1985) Use of Calcium-Channel Blocking Drugs in Hypertrophic Cardiomyopathy. Am J Cardiol 55:185B-195B
St John Sutton MG, Tajik AJ, Smith HG (1980) Angina in idiopathic hypertrophic subaortic stenosis. Circulation 61:561–568
Suwa M, Horita Y, Kawamura K (1984) Improvement in left ventricular diastolic function during intravenous and oral diltiazem therapy in patients with hypertrophic cardiomyopathy. An Echocardiographic Study. Am J Cardiol 54: 1047–1053
Tokushima T, Eguchi S, Ogata T, Eguchi Y, Hayano M, Matsuo S (1991) Evaluation of left ventricular function in patients with hypertrophic cardiomyopathy using equilibrium blood pool scintigraphy (in Japanese). Jpn J Appl Physiol 21:413–419
Toshima H, Koga Y, Nagata H, Toyomasu K, Itaya K, Maroba T (1986) Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double blind crossover study. Jpn Heart J 27:701–717
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tokushima, T., Utsunomiya, T., Ogawa, T. et al. Short- and long-term effects of nisoldipine on cardiac function and exercise tolerance in patients with hypertrophic cardiomyopathy. Basic Res Cardiol 91, 329–336 (1996). https://doi.org/10.1007/BF00789305
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00789305